WebMD Health (WBMD) Tops Q2 EPS by 1c

WebMD Health (NASDAQ: WBMD) reported Q2 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $167.6 million versus the consensus estimate of $165.4 million.

"WebMD's second quarter results reflect our consistent execution and leadership in a fast-paced, dynamic digital marketplace," said David Schlanger, Chief Executive Officer, WebMD. "We continue to invest in our user experience and advertiser products and are well positioned as a key partner to our biopharma and OTC/CPG customers. Today, we are pleased to reaffirm our strong outlook for 2016."

Financial Highlights

GUIDANCE:

WebMD Health sees Q3 2016 revenue of $168-171 million, versus the consensus of $168.8 million.

For earnings history and earnings-related data on WebMD Health (WBMD) click here.

You May Also Be Interested In

• MillerKnoll, Inc. (MLKN) Tops Q4 EPS by 4c
• Qualcomm expects $40bn in non-handset revenue by fiscal 2029
• Qualcomm targets $40B in non-handset revenue by fiscal 2029